Publicaciones
-
Deyà-Martinez A, Fortuny-Guasch C, Soler-Palacín P, Neth O, Sánchez E, Martín-Nalda A, Falcón-Neyra L, Vila A, Valls-Lafon A and Noguera-Julián A.
Cystatin C A Marker for Inflammation and Renal Function Among HIV-infected Children and Adolescents
PEDIATRIC INFECTIOUS DISEASE JOURNAL . 35(2): 196-200. Nº de citas: 14
-
Iveli P, Noguera-Julián A, Soler-Palacín P, Martín-Nalda A, Rovira-Girabal N, Fortuny-Guasch C and Figueras-Nadal C.
Hepatotoxicity in healthy infants exposed to nevirapine during pregnancy
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 34(1): 39-44. Nº de citas: 1
-
Agüero F, Cofan F, Fortuny-Guasch C, Lopez M, Manzardo C, Lonca M, Oppenheimer F, Moreno A, Campistol JM and Miro JM.
Pregnancy in a renal transplant recipient with HIV-1 infection: a case report
ANTIVIRAL THERAPY . 21(3): 267-271.
-
Calzada-Hernández J, Anton-Lopez J, Bou-Torrent R, Iglesias-Jimenez E, Ricart S, Martín-de-Carpi J, García de Vicuña-Muñoz C, Torrente V, Sánchez-Manubens J, Giménez-Roca CI, Rozas L, Juncosa-Morros T, Fortuny-Guasch C and Noguera-Julián A.
Tuberculosis in pediatric patients treated with anti-TNFa drugs: a cohort study
PEDIATRIC RHEUMATOLOGY . 13: 54-54. Nº de citas: 33
-
Noguera-Julián A, Morén C, Rovira N, Garrabou G, Catalán M, Sánchez E, Cardellach F, Miró Ó and Fortuny-Guasch C.
Decreased Mitochondrial Function Among Healthy Infants Exposed to Antiretrovirals During Gestation, Delivery and the Neonatal Period
PEDIATRIC INFECTIOUS DISEASE JOURNAL . 34(12): 1349-1354. Nº de citas: 15
-
Palladino C, Gómez ML, Soler-Palacín P, González-Tomé MI, De Ory SJ, Espiau M, Hoyos SP, León-Leal JA, Méndez M, Moreno-Pérez D, Fortuny-Guasch C, Sierra AM, Guruceta IP, Guillén SM and Briz V.
Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice
Aids . 29(16): 2155-2159. Nº de citas: 4
-
Martínez-Bonet M, Puertas MC, Fortuny-Guasch C, Ouchi D, Mellado J, Rojo P, Noguera-Julián A, Muñoz-Fernández MA and Martinez-Picado J.
Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy
CLINICAL INFECTIOUS DISEASES . 61(7): 1169-1178. Nº de citas: 95
-
Sollai S, Noguera-Julián A, Galli L, Fortuny-Guasch C, Deyà-Martinez A, de Martino M and Chiappini E.
Strategies for the Prevention of Mother to Child Transmission in Western Countries An Update
PEDIATRIC INFECTIOUS DISEASE JOURNAL . 34(5): 14-30. Nº de citas: 7
-
Fortuny-Guasch C, Deyà Á, Chiappini E, Galli L, De Martino M and Noguera-Julián A.
Metabolic and Renal Adverse Effects of Antiretroviral Therapy in HIV-infected Children and Adolescents
PEDIATRIC INFECTIOUS DISEASE JOURNAL . 34(5): 36-43. Nº de citas: 43
-
Falcon-Neyra L, Benmarzouk-Hidalgo OJ, Madrid L, Noguera-Julián A, Fortuny-Guasch C, Neth O and López-Cortés L.
No Differences of Immune Activation and Microbial Translocation Among HIV-infected Children Receiving Combined Antiretroviral Therapy or Protease Inhibitor Monotherapy
Medicine . 94(11): . Nº de citas: 4